UHPLC–MS/MS method for the quantification of ultra‐traces of irinotecan and its metabolites in red blood cells and plasma to detect caregivers' contamination

Abstract The occupational exposure of caregivers to antineoplastic agents has been demonstrated since 1979. Since the early 1990s, numerous studies from several countries have demonstrated the contamination of care facilities by antineoplastic drugs. As it is easier to sample, most contamination measurements in workers are carried out in urine sample. The distribution and elimination half‐lives of irinotecan suggest that blood can be considered as better than urine for the biomonitoring of a potential contamination of healthcare workers. We describe here the development and the validation of a UHPLC–MS/MS method to simultaneously quantify irinotecan, and two of its main metabolites, APC and SN‐38, at ultra‐trace levels in plasma and red blood cells (RBC). This method has been applied to blood samples collected from several healthcare services in a French comprehensive cancer center. The results demonstrate that the method is sensitive enough to identify a contamination of healthcare workers by irinotecan and SN‐38 at very low concentrations. Moreover, the results show that analysis of RBC is of great interest and complementary to that of serum.